The use of IFN-γ in the complex treatment of patients with destructive pulmonary TB with bacterial excretion has shown its high efficiency in the intensive phase of chemotherapy, accompanied by an increase in patients' quality of life. The gene discussed is IFNG; the disease is pulmonary tuberculosis.